(29 April 2020) Novaferon- 3-day reduction of time to SARS-CoV-2 clearance
A Novel Protein Drug, Novaferon, as the Potential Antiviral Drug for COVID-19 https://www.medrxiv.org/content/10.1101/2020.04.24.20077735v1 The antiviral effects of Novaferon for COVID-19 patients were in consistence with the laboratory findings. Novaferon inhibited the viral replication in infected cells (EC50=1.02 ng/ml), and protected… Continue reading "(29 April 2020) Novaferon- 3-day reduction of time to SARS-CoV-2 clearance"